Aptevo Therapeutics
Price & Volume
Stats
See more52W Range | $0.74-$27.72 |
Market Cap | $2.2M |
Shares Short | 71,260 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $345,000 |
Diluted EPS | $66.96 |
News
See moreYahoo Finance • yesterday
Aptevo Therapeutics announces exercise of existing warrants for $3M gross proceeds
Yahoo Finance • 2 months ago
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
Yahoo Finance • last year
Aptevo Therapeutics GAAP EPS of -$2.23 misses by $0.14
Yahoo Finance • last year
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
About
CEO | Mr. Jeffrey G. Lamothe CA |
CFO | Ms. Daphne L. Taylor CPA |
Address | 2401 4th Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 33 |